When preparing an Illumina library, we always talk about "Adapter-dimers", but what is the Specific structure of a dimer? And how can I detect or observe it?
Any ideas?
Any ideas?
-
-
For artifact-dimers, if the sequences are identical and you have paired reads, you can find them by merging reads via overlap and looking in the insert size histogram for sharp peaks at specific insert sizes (e.g. a sharp peak at 62bp would indicate dimers of some 31bp sequence). These reads should not map to the reference.
Generally, if you have sharp peaks in the insert size histogram from overlap that are not present in the insert size histogram from mapping, these are probably artifacts.
If you know the artifact sequence, you can also find (or trim, or filter) artifacts by searching for reads containing the sequence in question using a tool like BBDuk. An adapter dimer should have adapter sequence starting at position 0. -
thx Brian,
but i just want to know what is the specific structure of the artifact-dimers,
i couldn't understand how two adapters ligate with each other.
could you simply describe the molecule mechanism?
Thank you.Comment
-
I'm a programmer with some knowledge of chemistry. Everything I know about sequencing has been taught to me by people more familiar with biology and/or kinetics. So no, I can't tell you anything about which non-genomic artifacts will preferentially ligate; sorry! All I can tell you is how to detect them. But I'm sure someone on this forum can better help you.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment